HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kathleen M Mahoney Selected Research
Kathleen M Mahoney Research Topics
Disease
14
Neoplasms (Cancer)
01/2022 - 12/2011
7
Melanoma (Melanoma, Malignant)
01/2022 - 11/2014
4
Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 01/2016
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2015 - 04/2015
2
Urinary Bladder Neoplasms (Bladder Cancer)
04/2015 - 11/2014
2
Hodgkin Disease (Hodgkin's Disease)
04/2015 - 11/2014
1
Hypoxia (Hypoxemia)
01/2022
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1
Leukemia
01/2021
1
Tics (Tic)
01/2019
1
Lung Neoplasms (Lung Cancer)
04/2015
1
Cardiac Tamponade
07/2013
1
Breast Neoplasms (Breast Cancer)
12/2011
Drug/Important Bio-Agent (IBA)
6
Biomarkers (Surrogate Marker)
IBA
01/2022 - 11/2014
5
Nivolumab
IBA
01/2022 - 11/2014
3
B7-H1 Antigen
IBA
01/2020 - 08/2015
3
pembrolizumab
IBA
12/2015 - 11/2014
2
Antibodies
IBA
01/2020 - 12/2015
2
Programmed Cell Death 1 Receptor
IBA
01/2017 - 08/2015
2
atezolizumab
IBA
04/2015 - 11/2014
2
Ipilimumab
IBA
04/2015 - 11/2014
1
Fatty Acids (Saturated Fatty Acids)
IBA
01/2022
1
Mechanistic Target of Rapamycin Complex 1
IBA
01/2022
1
Androgens
IBA
01/2022
1
RNA (Ribonucleic Acid)
IBA
10/2021
1
Vaccines
IBA
01/2021
1
Antigens
IBA
01/2021
1
Cytokines
IBA
01/2017
1
temsirolimus
FDA Link
01/2016
1
Proteins (Proteins, Gene)
FDA Link
01/2016
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2016
1
TOR Serine-Threonine Kinases
IBA
01/2016
1
Bevacizumab (Avastin)
FDA Link
01/2016
1
Coloring Agents (Dyes)
IBA
12/2015
1
CTLA-4 Antigen
IBA
08/2015
1
Immune Checkpoint Inhibitors
IBA
04/2015
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
04/2015
1
Dacarbazine (DIC)
FDA Link
Generic
04/2015
1
Monoclonal Antibodies
IBA
04/2015
1
Ligands
IBA
11/2014
1
Vemurafenib
IBA
07/2013
1
Trastuzumab (Herceptin)
FDA Link
12/2011
1
Hormones (Hormone)
IBA
12/2011
Therapy/Procedure
7
Therapeutics
01/2022 - 12/2011
5
Immunotherapy
10/2021 - 08/2015
1
Drug Therapy (Chemotherapy)
12/2011